Acknowledgements
Cancer
CANCER
This study was funded by Ono Pharmaceutical Co., Ltd. The authors are grateful for the patients, investigators, and staff at Tohoku University Graduate School of Medicine, Cancer Institute Hospital, National Cancer Center Hospital, Tokai University, and Aichi Cancer Center for the contributions to this study. The authors thank the members of the Efficacy and Safety Monitoring Committee: Kazuo Tamura (General Medical Research Center, Fukuoka University, Fukuoka), Kunihiro Tsukasaki (International Medical Center, Saitama Medical University, Saitama), and Hirokazu Nagai (Nagoya Medical Center, Nagoya). The authors also thank Nicholas D. Smith (EMC K.K.) for medical writing support, which was funded by Ono Pharmaceutical Co., Ltd.